RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 79 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $753 | -98.6% | 42,297 | +1662.4% | 0.00% | – |
| Q4 2019 | $55,000 | -46.1% | 2,400 | -50.0% | 0.00% | – |
| Q3 2019 | $102,000 | +96.2% | 4,800 | +100.0% | 0.00% | – |
| Q2 2019 | $52,000 | -20.0% | 2,400 | 0.0% | 0.00% | – |
| Q1 2019 | $65,000 | +1.6% | 2,400 | 0.0% | 0.00% | – |
| Q4 2018 | $64,000 | -8.6% | 2,400 | 0.0% | 0.00% | – |
| Q3 2018 | $70,000 | -6.7% | 2,400 | 0.0% | 0.00% | – |
| Q2 2018 | $75,000 | +59.6% | 2,400 | 0.0% | 0.00% | – |
| Q1 2018 | $47,000 | -31.9% | 2,400 | 0.0% | 0.00% | – |
| Q4 2017 | $69,000 | – | 2,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 4,909,956 | $142,977,919 | 8.04% |
| Opaleye Management Inc. | 735,000 | $21,403,200 | 7.44% |
| Frazier Life Sciences Management, L.P. | 1,894,000 | $55,153,280 | 3.43% |
| RA Capital Management | 5,516,067 | $160,627,871 | 3.26% |
| Altium Capital Management LP | 170,000 | $4,950,400 | 2.52% |
| Samsara BioCapital, LLC | 345,293 | $10,054,932 | 2.16% |
| Rock Springs Capital Management LP | 1,760,865 | $51,276,389 | 1.23% |
| Parkman Healthcare Partners LLC | 157,862 | $4,596,941 | 1.22% |
| Baker Brothers Advisors | 6,354,608 | $185,046,185 | 1.11% |
| EAM Investors, LLC | 164,695 | $4,795,918 | 0.99% |